Aastrom Biosciences
Aastrom Biosciences reports interim data from phase I/II trial of tissue repair cells
Published in Telemedicine Business Week, October 18th, 2006
Of the 36 patients enrolled in the U.S. Food and Drug Administration (FDA) approved trial, interim results were reported on 23 patients, including 12 patients who completed the total trial observation period of 12 months by August 2006. Of the 12 patients who have completed the 1 year follow-up period, 10 showed bone bridging at the fracture site, indicating radiographic evidence of healing.
At this time, two...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Business Week
More Articles from Telemedicine Business Week
- AFP Imaging
AFP Imaging reports profitable fourth quarter - Asian Institute of Gastroenterology, India
Pancreatic ductal stones are safely managed with extracorporeal shockwave lithotripsy - Azienda Ospedaliero-Universitaria di Ferrara, Italy
Nuclear medicine imaging of bone infections is reviewed - Cambridge University Hospitals NHS Foundation Trust, U.K.
Sclerosing mesenteritis CT features described - Canon
Canon expands digital radiography offerings with introduction of Canon CXDI-40EC System - Cardiac Science
Cardiac Science launches HeartCentrix software solution connecting diagnostics with medical records - More from this issue of Telemedicine Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
